Product Information
BUPROPION HCL XL 300 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.1515 per EA under NDC 00527243046. Its NADAC has been published 119 times since Aug 10, 2022.
Strength
300 mg/1
Manufacturer
Lannett Company Inc.NDC
00527243046
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
10/23/2024
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208652On Market Since
1/8/2018
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 300 MG TABLET has been published 119 times since Aug 10, 2022, and over the history we have for it it has declined 8.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1515 per EA |
|---|---|
| All-time high | $0.1988 (Feb 14, 2024) |
| All-time low | $0.1326 (Jul 17, 2024) |
| Median price | $0.1624 |
| Average price | $0.1639 |
| Largest weekly change | -27.4% (Feb 21, 2024) |
| Weeks tracked | 119 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 300 MG TABLET, manufactured by Lannett Company Inc., is $0.1515 per EA (NDC 00527243046), effective Nov 13, 2024.
How has the price of BUPROPION HCL XL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 300 MG TABLET has declined 8.1%. It has been tracked across 119 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 300 MG TABLET?
Since Aug 10, 2022, the NADAC for BUPROPION HCL XL 300 MG TABLET has ranged from a low of $0.1326 (Jul 17, 2024) to a high of $0.1988 (Feb 14, 2024), with a median of $0.1624 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 300 MG TABLET?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUPROPION HCL XL 300 MG TABLET, is $0.1033 per EA — about 32% below BUPROPION HCL XL 300 MG TABLET.
Who manufactures BUPROPION HCL XL 300 MG TABLET?
BUPROPION HCL XL 300 MG TABLET (NDC 00527243046) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification